Pharmaceutical industry
The US biotechnology industry, comprising approximately 1,500 companies, boasts combined annual revenue of about $70 billion. Major players in this sector include Amgen, Biogen Idec, Genentech, Genzyme, Life Technologies, and Monsanto, which are driving innovation through biotech research in medicine, agriculture, food, and science. The industry's profitability
Pharmaceutical industry
As the global economic recovery remains a topic of concern, the European Central Bank (ECB) stepped in to alleviate credit issues by lending 131.9 billion euros ($161 billion) to banks for three months. Meanwhile, U.S. stocks advanced on the back of this move, while Asian markets traded sideways
Pharmaceutical industry
The global nucleic acid testing market is expected to experience significant growth, reaching $13.8 billion by 2015. This market is driven by the increasing demand for genetic testing, advances in technology, and the need for personalized medicine. The report profiles 46 key and niche players in the industry, including
Pharmaceutical industry
Radient Pharmaceuticals Corporation and Jaiva Technologies, Inc. have announced plans to submit a clinical trial application to the Central Drugs Standard Control Organization (CDSCO) in India to commence human phase II trials for Radient's Combination Immunogene Therapy (CIT) technology as a vaccine therapy for non-small cell lung carcinoma
Pharmaceutical industry
Research published in Cancer Research has identified 100 genes whose knockdown affects lethality to bortezomib, a proteasome inhibitor used in cancer treatment. A genome-wide siRNA screen was performed to evaluate the genetic determinants that confer sensitivity to bortezomib, revealing common pathways linked to cell death. The study suggests that proteasome
Pharmaceutical industry
Indian drugmaker Cipla Ltd. plans to sell copies of Roche Holding AG and Amgen Inc.'s best-selling biotechnology medicines in China, marking a significant expansion in the country's biotech sector. Cipla Chairman Yusuf Hamied aims to invest in companies in India and Hong Kong that make monoclonal
Pharmaceutical industry
Cipla Ltd., an Indian drugmaker, plans to replicate Roche Holding AG's and Amgen Inc.'s best-selling biotechnology medicines with a partner in China. This new strategy aims to make affordable copies of high-profile treatments, including Roche's Avastin and Herceptin cancer drugs, and Amgen's
Pharmaceutical industry
Privately held biotech firm TransTech Pharma Inc. has entered into a collaborative agreement with Forest Laboratories Inc. to develop and commercialize a new class of glucose-lowering agents, known as functionally liver-selective glucokinase activators (GKAs). This innovative partnership is expected to yield over $1.1 billion in revenue for TransTech, with
Pharmaceutical industry
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company have completed enrollment in a phase II clinical trial of brentuximab vedotin (SGN-35), an antibody-drug conjugate (ADC) targeted to CD30, for relapsed or refractory systemic anaplastic large cell lymphoma (ALCL). The trial enrolled 55 patients and will provide preliminary data in
Pharmaceutical industry
The global market for H1N1 vaccines has seen significant growth and development over the years, with various companies contributing to the production and distribution of these vaccines. The report by Research and Markets provides an in-depth analysis of the global H1N1 vaccines market, covering the period from 2009 to 2015.
Pharmaceutical industry
The global liver cancer drugs market is expected to reach $1.35 billion by 2015, driven by the growing prevalence of liver cancer and the increasing adoption of targeted therapies. According to a new report, the market for liver cancer drugs will experience significant growth over the next few years,
Pharmaceutical industry
Researchers at the Cancer Therapy & Research Center at the University of Texas Health Science Center in San Antonio have begun enrolling patients in a US Phase II clinical trial using a novel combination of Reolysin and gemcitabine to treat advanced pancreatic cancer. This study aims to determine the clinical
